A health care professional swab tests a patient for coronavirus at drive-through testing outside the Emergency Room entrance at Beth Israel Deaconess Hospital in Milton, MA on March 30, 2020.The U.S.
Food and Drug Administration has issued the first emergency use authorization for a new category of tests, known as a covid-19 antigen test, to help rapidly detect coronavirus.
The main advantage of the antigen test is that it can provide results in minutes. However, it can't detect all active infections, unlike polymerase chain reaction tests which are much more accurate but take longer to show results.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WSJ News Exclusive | FDA Pulls Approval for Dozens of Mask Makers in ChinaFederal officials withdrew approval for more than 60 manufacturers in China to export N95-style masks to the U.S. after finding what they said were a large number of low-quality products from those companies
Read more »
FDA approves phase 2 trial for coronavirus vaccine“Around the world you are seeing unprecedented public sector and private sector collaboration,” Dr. Kavita Patel says on developing a coronavirus vaccine. “But we have to take the time to make sure that we do not create more harm.”
Read more »
FDA approves second round of coronavirus vaccine trials, could reach third trial by summerBiotech Moderna received the FDA's authorization to conduct a second phase of clinical trials as it works to develop a vaccine against the virus.
Read more »
FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus TestThe FDA granted its first-ever emergency use authorization for the gene-editing technology Crispr—greenlighting a coronavirus diagnostic test developed by Cambridge, Massachusetts-based Sherlock Biosciences
Read more »
The FDA Has Approved a Coronavirus Vaccine for Phase Two TrialThe FDA has given Moderna the green light to enter into phase two of trials with its vaccine against the novel coronavirus that causes COVID-19
Read more »